Vera Therapeutics reported cash from operations of -$100.25M and free cash flow of -$100.25M for the quarter ended Jun 2026, down 83.0% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||
| Net Income | -7.25M | -16.60M | -17.11M | -14.92M | -24.82M | -33.29M | -30.51M | -20.64M | -20.54M | -26.12M | -28.83M | -34.15M | -46.98M | -44.12M | -52.08M | -75.69M | -80.16M | -90.59M | -120.60M | -108.99M | ||||||
| Share-based Compensation | 2.89M | 0.96M | 3.49M | 3.80M | 3.77M | 2.75M | 5.65M | 5.85M | 5.73M | 3.22M | 6.48M | 6.25M | 6.49M | 6.22M | 7.74M | 9.47M | 9.74M | 10.96M | 13.21M | 15.86M | ||||||
| Gains from Investment Securities | 0.01M | 0.14M | 0.13M | |||||||||||||||||||||||
| Cash from Operations | -5.48M | -6.44M | -8.98M | -19.03M | -18.42M | -21.16M | -26.29M | -17.77M | -22.97M | -25.14M | -33.83M | -24.78M | -36.88M | -39.18M | -54.41M | -54.80M | -61.91M | -69.99M | -106.50M | -100.25M | ||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||
| Amortizatization of Intangibles | 0.56M | 0.55M | 0.56M | 0.59M | 0.58M | 0.56M | 0.55M | 0.53M | 0.52M | 0.50M | 0.50M | 0.55M | 0.46M | 0.44M | 0.43M | 0.11M | 0.12M | 0.12M | ||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.01M | 0.00M | 0.01M | 0.01M | 0.02M | 0.06M | 0.09M | 0.12M | 0.13M | 0.14M | 0.14M | 0.13M | ||||||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||
| Change in Account Payables | -0.76M | 0.42M | 5.94M | -0.24M | -0.07M | 4.98M | -6.67M | 7.95M | -0.98M | -1.18M | -5.91M | -0.55M | -0.06M | 3.06M | 1.60M | 3.90M | 4.79M | 3.62M | -7.97M | 0.66M | ||||||
| Change in Accured Expenses | 1.02M | 3.22M | 4.22M | -2.41M | 0.47M | 4.75M | 4.64M | -4.61M | -1.19M | -1.05M | -1.69M | 4.58M | 8.07M | -3.77M | -4.78M | 8.10M | 3.92M | 7.21M | -0.44M | 2.51M | ||||||
| Other Working Capital Changes | -0.63M | -0.71M | 3.94M | 3.60M | 0.15M | 0.48M | -3.75M | 2.30M | -0.55M | -0.65M | -0.64M | -1.69M | 0.45M | -0.53M | 5.88M | -1.71M | -0.61M | 0.37M | 5.14M | 9.43M | ||||||
| Investing Activities | ||||||||||||||||||||||||||
| Capital Expenditures | 5.00M | 0.02M | 0.01M | 0.04M | 0.06M | 0.09M | 0.24M | 0.65M | 0.19M | 0.21M | 0.13M | 0.10M | 0.02M | |||||||||||||
| Change in Acquisitions & Divestments | 16.00M | 38.00M | 24.00M | 36.90M | 22.40M | 44.90M | 71.82M | 31.68M | 58.50M | 111.50M | 73.28M | 106.25M | 126.06M | 168.59M | 105.27M | 87.92M | 131.03M | |||||||||
| Cash from Investing Activities | -5.00M | -39.45M | -42.09M | -2.44M | 13.44M | 12.23M | -86.45M | 16.23M | 18.56M | -219.29M | -22.68M | 38.32M | -221.38M | 15.32M | 28.54M | 69.76M | 80.66M | -137.82M | 32.86M | |||||||
| Financing Activities | ||||||||||||||||||||||||||
| Other financing activities | 0.23M | 0.05M | 0.97M | 0.83M | 0.24M | 0.43M | 0.30M | 0.09M | 6.91M | 3.44M | 0.75M | 2.31M | 1.53M | 0.46M | 0.80M | 4.19M | 3.94M | 1.92M | ||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||
| Long-Term Debt Issuances | ||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 0.15M | 0.02M | 0.01M | 0.20M | 0.41M | 0.00M | 0.04M | 0.05M | 0.11M | 0.71M | 0.36M | 0.10M | 1.49M | 0.10M | 0.05M | 0.00M | 2.31M | 0.16M | 0.17M | |||||||
| Net Equity Issued and Repurchased | -51.18M | 86.13M | ||||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||
| Cash from Financing Activities | 4.92M | 80.27M | 0.05M | 0.91M | 20.71M | 107.98M | 0.43M | 0.30M | 24.83M | 276.54M | 3.44M | 0.74M | 325.95M | 1.53M | 20.29M | 0.80M | 286.28M | 3.94M | 1.92M | |||||||
| Change in Cash | -5.48M | -6.52M | 31.83M | -61.08M | -19.95M | 12.98M | 93.93M | -103.79M | -6.45M | 18.24M | 23.42M | -44.02M | 2.17M | 65.39M | -37.56M | -5.97M | 8.65M | 296.95M | -240.37M | -65.47M | ||||||
| Free Cash Flow | -5.48M | -11.44M | -9.00M | -19.04M | -18.46M | -21.16M | -26.29M | -17.77M | -22.97M | -25.21M | -33.83M | -24.87M | -37.12M | -39.83M | -54.59M | -55.01M | -62.04M | -70.10M | -106.52M | -100.25M | ||||||
| Net Cash Flow | -5.48M | -6.52M | 31.83M | -61.08M | -19.95M | 12.98M | 93.93M | -103.79M | -6.45M | 18.24M | 23.42M | -44.02M | 2.17M | 65.39M | -37.56M | -5.97M | 8.65M | 296.95M | -240.37M | -65.47M |